Associations between myeloperoxidase and paraoxonase-1 and type 2 diabetes in patients with ischemic heart disease

被引：0
|
作者：
Katarzyna Nessler
Rafal Grzybczak
Michal Nessler
Jarosław Zalewski
Grzegorz Gajos
Adam Windak
机构：
[1] Jagiellonian University Medical College in Krakow,Department of Family Medicine, Chair of Internal Medicine and Gerontology
[2] Jagiellonian University Medical College,Department of Cardiac Rehabilitation, Institute of Cardiology
[3] Rydygier Memorial Hospital,Burns and Plastic Surgery Centre of Malopolska
[4] Jagiellonian University Medical College,Department of Coronary Disease and Heart Failure, Institute of Cardiology
[5] John Paul II Hospital,undefined
来源：
BMC Cardiovascular Disorders | / 22卷
关键词：
Dysfunctional high-density lipoprotein; Myeloperoxidase (MPO); Paraoxonase-1 (PON-1); Type 2 diabetes; Ischemic heart disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Stratification of patients with type 2 diabetes mellitus for painless ischemic heart disease
    Volkova, N. I.
    Harahashyan, A. V.
    Sorokina, Yu. A.
    Davidenko, I. Yu.
    DIABETES MELLITUS, 2012, 15 (01): : 19 - 24
  • [32] Cerebral infarction and ischemic heart disease in type 2 diabetes mellitus patients
    Kitagawa, M
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 154 - 155
  • [33] Cardiointervent therapy of patients with type 2 diabetes mellitus with ischemic heart disease
    Buziashvili, Y., I
    Asymbekova, E. U.
    Matskeplishvili, S. T.
    Tugeeva, E. F.
    Nersesyants, L. L.
    Barkalaya, L. R.
    Shuvaev, I. P.
    DIABETES MELLITUS, 2008, 11 (01): : 35 - 39
  • [34] Relationship between MPV and paraoxonase-1 activity, brachial artery diameter and IMT in patients with diabetes mellitus
    Karakaya, Pinar
    Okuturlar, Yildiz
    Mert, Meral
    Gedikbasi, Asuman
    Islim, Filiz
    Acarer, Didem
    Kocamaz, Nursel
    Soyluk, Ozlem
    Ayaz, Teslime
    Alarslan, Pinar
    Harmankaya, Ozlem
    Kumbasar, Abdulbaki
    JOURNAL OF ENDOCRINOLOGY METABOLISM AND DIABETES OF SOUTH AFRICA, 2016, 21 (03) : 40 - 46
  • [35] Paraoxonase-1 and the risk for coronary heart disease in a general population of dutch women
    Van Himbergen, TM
    van der Schouw, YT
    Voorbij, HA
    Peeters, PH
    Roest, M
    CIRCULATION, 2005, 112 (17) : U868 - U869
  • [36] Unexpectedly higher diazoxon hydrolysis by serum paraoxonase-1 in coronary heart disease
    Mackness, Bharti
    Mackness, Mike
    CLINICAL BIOCHEMISTRY, 2019, 65 : 21 - 23
  • [37] Paraoxonase-1 is not associated with coronary artery calcification in type 2 diabetes: Results from the PREDICT study
    Mackness, Bharti
    Marsillach, Judit
    Elkeles, Robert S.
    Godsland, Ian F.
    Feher, Michael D.
    Rubens, Michael B.
    Flather, Marcus D.
    Humphries, Steve E.
    Cooper, Jackie
    Mackness, Mike
    DISEASE MARKERS, 2012, 33 (02) : 101 - 112
  • [38] The most effective polymorphisms of paraoxonase-1 gene on enzyme activity and concentration of paraoxonase-1 protein in type 2 diabetes mellitus patients and non-diabetic individuals: A systematic review and meta-analysis
    Hashemi, Mohammad Mostakhdem
    Mousavi, Elham
    Arab-Bafrani, Zahra
    Nezhadebrahimi, Abbas
    Marjani, Abdoljalal
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 152 : 135 - 145
  • [39] PARAOXONASE-1 ACTIVITY IN PATIENTS WITH ANGIOGRAPHICALLY ASSESSED PERIPHERAL ARTERIAL DISEASE
    Perkov, S.
    Paro, M. M. Kardum
    Vidjak, V.
    Novacic, K.
    Flegar-Mestric, Z.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 220 - 220
  • [40] Paraoxonase-1 and Simvastatin Treatment in Patients with Stable Coronary Artery Disease
    Januszek, Rafal
    INTERNATIONAL JOURNAL OF VASCULAR MEDICINE, 2016, 2016
12345